CONCIT PHARMA HOLDING ApS: Financial statements 2023
CVR: 33061374
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
CONCIT PHARMA HOLDING ApS (CVR 33061374) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -31,247 and a net result of DKK -31,768 compared with DKK -186,796 the year before. Equity in the 2023 report amounted to DKK 656,068. The solvency ratio was 89.5%.
- Gross Profit
- DKK -31,247
- Profit/Loss
- DKK -31,768
- Equity
- DKK 656,068
- Total Assets
- DKK 732,751
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -31 t. | -32 t. | 656 t. | - |
| 2022 | - | -27 t. | -187 t. | 688 t. | - |
| 2021 | - | -28 t. | -1.1 mio. | 875 t. | - |
| 2020 | - | -38 t. | -18 t. | 3 mio. | - |
| 2019 | - | -173 t. | -479 t. | 6 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
CONCIT PHARMA HOLDING ApS has published its annual report for 2022. Gross profit came to DKK -27,487, and the net result was DKK -186,796.
About CONCIT PHARMA HOLDING ApS
CONCIT PHARMA HOLDING ApS was a Danish company of the type Anpartsselskab based in Jyderup, founded in 2010. The company has been dissolved on 13 January 2025. The company was registered under the industry Ikke-finansielle holdingselskaber. In 2023, the company reported a gross profit of DKK -31,247 and a net result of DKK -31,768 compared with DKK -186,796 the year before. Equity in the 2023 report amounted to DKK 656,068.